<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Complexity of pathomechanisms leading to diastolic heart failure in diabetes mellituspotential field for therapeutic interventions?</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><forename type="first">Michael</forename><surname>Schwarzer</surname></persName>
							<email>michael.schwarzer@med.uni-jena.de</email>
							<idno type="ORCID">0000-0001-9698-4830</idno>
							<affiliation key="aff0">
								<orgName type="department">Department of Cardiothoracic Surgery</orgName>
								<orgName type="institution">University Hospital Jena, -Friedrich-Schiller-University Jena</orgName>
								<address>
									<addrLine>Am Klinikum 1</addrLine>
									<postCode>D-07747</postCode>
									<settlement>Jena</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Department of Cardiothoracic Surgery</orgName>
								<orgName type="institution">University Hospital Jena, -Friedrich-Schiller-University Jena</orgName>
								<address>
									<addrLine>Am Klinikum 1</addrLine>
									<postCode>D-07747</postCode>
									<settlement>Jena</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Michel</forename><surname>Noutsias</surname></persName>
							<idno type="ORCID">0000-0001-9698-4830</idno>
							<affiliation key="aff2">
								<orgName type="department" key="dep1">Department of Internal Medicine I</orgName>
								<orgName type="department" key="dep2">Division of Cardiology, Pneumology, Angiology and Intensive Medical Care</orgName>
								<orgName type="institution">University Hospital Jena</orgName>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="institution">Friedrich-Schiller-University Jena</orgName>
								<address>
									<addrLine>Am Klinikum 1</addrLine>
									<postCode>D-07747</postCode>
									<settlement>Jena</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Frank</forename><surname>Spillmann</surname></persName>
							<affiliation key="aff4">
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution" key="instit1">Charité -Universitätsmedizin Berlin</orgName>
								<orgName type="institution" key="instit2">Campus Virchow Klinikum (CVK)</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="institution" key="instit1">Deutsches Zentrum für Herz Kreislaufforschung (DZHK) -Standort Berlin</orgName>
								<orgName type="institution" key="instit2">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<addrLine>Campus Virchow Klinikum (CVK)</addrLine>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff6">
								<orgName type="department">Berlin Center for Regenerative Therapies (BCRT)</orgName>
								<address>
									<addrLine>Campus Virchow Klinikum (CVK)</addrLine>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">P</forename><forename type="middle">Christian</forename><surname>Schulze</surname></persName>
							<affiliation key="aff2">
								<orgName type="department" key="dep1">Department of Internal Medicine I</orgName>
								<orgName type="department" key="dep2">Division of Cardiology, Pneumology, Angiology and Intensive Medical Care</orgName>
								<orgName type="institution">University Hospital Jena</orgName>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="institution">Friedrich-Schiller-University Jena</orgName>
								<address>
									<addrLine>Am Klinikum 1</addrLine>
									<postCode>D-07747</postCode>
									<settlement>Jena</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Torsten</forename><surname>Doenst</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Cardiothoracic Surgery</orgName>
								<orgName type="institution">University Hospital Jena, -Friedrich-Schiller-University Jena</orgName>
								<address>
									<addrLine>Am Klinikum 1</addrLine>
									<postCode>D-07747</postCode>
									<settlement>Jena</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Department of Cardiothoracic Surgery</orgName>
								<orgName type="institution">University Hospital Jena, -Friedrich-Schiller-University Jena</orgName>
								<address>
									<addrLine>Am Klinikum 1</addrLine>
									<postCode>D-07747</postCode>
									<settlement>Jena</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Carsten</forename><surname>Tschöpe</surname></persName>
							<affiliation key="aff4">
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution" key="instit1">Charité -Universitätsmedizin Berlin</orgName>
								<orgName type="institution" key="instit2">Campus Virchow Klinikum (CVK)</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="institution" key="instit1">Deutsches Zentrum für Herz Kreislaufforschung (DZHK) -Standort Berlin</orgName>
								<orgName type="institution" key="instit2">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<addrLine>Campus Virchow Klinikum (CVK)</addrLine>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff6">
								<orgName type="department">Berlin Center for Regenerative Therapies (BCRT)</orgName>
								<address>
									<addrLine>Campus Virchow Klinikum (CVK)</addrLine>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Complexity of pathomechanisms leading to diastolic heart failure in diabetes mellituspotential field for therapeutic interventions?</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">4BE09BF2413DDC0C1305BA8C607A6607</idno>
					<idno type="DOI">10.1186/s12872-017-0688-x</idno>
					<note type="submission">Received: 1 June 2017 Accepted: 15 September 2017</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:32+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Advanced glycation end products (AGE) have been implicated in diabetes associated complications.</s><s>They have been suggested as potential mediators in the progression of diabetic heart failure and as a potential target for treatment.</s><s>Brunvand et al. now provided evidence in that the suggested causal relationship between AGE and diastolic myocardial dysfunction cannot be confirmed in children with type 1 diabetes.</s><s>The early signs of diastolic myocardial impairment were associated with higher BMI, but not with HbA1c levels.</s><s>Furthermore, higher serum levels of MG-H1 and increased arterial stiffness were not significantly associated with diastolic dysfunction.</s><s>The lack of association argues against an essential role of AGEs.</s><s>This sobering finding does not support the potential to treat diastolic dysfunction by reduction approaches AGE in type 1 diabetic patients.</s><s>Further pathogenic mechanisms involved in diabetic cardiomyopathy, such as alterations of calcium metabolism, or remodeling of the extracellular matrix, and intramyocardial inflammation may be further promising therapeutic targets.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Diabetes is associated with a high risk of developing heart failure.</s><s>High glucose levels have been suggested as major factor in the development of comorbidities, which have a substantial adverse prognostic impact.</s><s>High glucose levels carry the risk of non-enzymatically reacting with proteins to form advanced glycation end products (AGE).</s><s>These AGEs have been implicated in diabetesrelated complications <ref type="bibr" target="#b0">[1]</ref>.</s><s>Multiple investigations have shown an association between increased AGE and arterial stiffness and/or impaired ventricular function.</s><s>However, it is not known whether AGEs are causally related to diabetic comorbidities.</s><s>Already in young type 1 diabetic patients without complications, increased AGE plasma levels have been reported <ref type="bibr" target="#b1">[2]</ref>.</s><s>Furthermore, plasma AGE levels have been associated with elevated hemoglobin A1c and indices of membrane alterations <ref type="bibr" target="#b2">[3]</ref>.</s><s>AGE has also been suggested as an environmental risk factor for the development of type 1 diabetes <ref type="bibr" target="#b3">[4]</ref>.</s></p><p><s>Brunvand et al. investigated, to the best of our knowledge, for the first time the association of AGEs with early diastolic dysfunction in type 1 diabetic patients <ref type="bibr" target="#b4">[5]</ref>.</s><s>The study confirmed an association of an early loss of diastolic function and BMI, higher systolic blood pressure and higher diastolic blood pressure.</s><s>However, there was no association between HbA1c or AGE levels and diastolic function in a logistic regression model.</s><s>As a consequence, Brunvand et al. suggest that the diastolic dysfunction may be partly caused or initiated by factors present before the start of insulin treatment, and may thus not necessarily be reflected by HbA1c levels.</s><s>Thus, the current investigation challenges one current major hypothesis of a substantial pathogenic role of AGE as a major contributor for the development of diastolic dysfunction in Type 1 diabetes patients.</s></p><p><s>With regard to the methodology of this report, we should consider that several parameters should be confirmed for the echocardiographic evaluation of diastolic heart failure <ref type="bibr" target="#b5">[6]</ref>.</s><s>Nonetheless, the authors have previously shown that the sole parameter used in their investigation, namely E'/A'-ratio &lt; 2.0, shows a high diagnostic reliability <ref type="bibr" target="#b6">[7]</ref>.</s><s>Addressing the data conveyed by the publication, we propose that further multiple pathomechanisms than the ones studied in this report might be more relevant for the development of diastolic dysfunction in Type 1 diabetes, which ultimately might also be true for Type 2 diabetes patients.</s><s>These include oxidative stress <ref type="bibr" target="#b7">[8]</ref>.</s><s>Impaired nitric oxide (NO) production affects endothelial repair mechanisms leading to endothelial dysfunction and to increased endothelial permeability <ref type="bibr" target="#b8">[9,</ref><ref type="bibr" target="#b9">10]</ref>.</s><s>Hyperglycemia induces reactive oxygen species (ROS) production, contributing to endothelial dysfunction, which precedes the manifestation of atherosclerosis <ref type="bibr" target="#b10">[11]</ref>.</s><s>Increased ROS induce inflammatory transcription factor (NF-kB) activation <ref type="bibr" target="#b9">[10]</ref>, which may ultimately also contribute to intramyocardial low-level inflammation in diabetic cardiomyopathy, accompanied by a compromise of hemodynamic parameters, including impairment of diastolic function parameters <ref type="bibr" target="#b11">[12]</ref>.</s><s>Myocardial inflammation might be profoundly involved in the significant remodeling in diabetic cardiomyopathy <ref type="bibr" target="#b12">[13]</ref>.</s><s>Since these pathogenic mechanisms have been effectively blunted in experimental diabetic cardiomyopathy, including the improvement of defective sarcoplasmic reticulum Ca 2+ transport <ref type="bibr" target="#b13">[14]</ref>, they appear a promising field to address mechanisms which effectively might prevent progression of diabetes related cardiovascular complications.</s><s>The AGEs instead, appear no longer a promising target for the prevention of Type 1 and Type 2 diabetic complications.</s></p><p><s>It may be concluded that the current report by Brunvand et al. "resets" our current understanding of the relevant pathomechanisms of diastolic dysfunction in diabetes mellitus.</s><s>AGEs may not be causally involved, eliminating also a causal treatment option, in this regard.</s><s>Thus, the search continues, and based on the abovementioned possibilities, at least the future outlook "is still sweet".</s></p></div>		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgements</head><p><s>We thank Benjamin Gloy for the help with manuscript submission.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Funding MN and CT have received grants by the Deutsche Forschungsgemeinschaft (DFG) through the Sonderforschungsbereich Transregio 19 "Inflammatory Cardiomyopathy" (SFB TR19; TP B2, TP B5 and Z3).</s><s>MN has received a grant by the University Hospital Giessen and Marburg Foundation Grant "T cell functionality" (UKGM 10/2009).</s><s>MN has been consultant to the IKDT (Institute for Cardiac Diagnosis and Therapy GmbH, Berlin) 2004-2008, and has received honoraria for presentations and/or participated in advisory boards from AstraZeneca, Bayer, Fresenius, Miltenyi Biotech, Novartis, Pfizer and Zoll.</s><s>TD and MS have received grants by the Deutsche Forschungsgemeinschaft (DFG) (DO602/10-1) and (SCHW1811/1-1).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Availability of data and materials not applicable</head><p><s>Authors' contributions MS and MN have drafted the manuscript.</s><s>MS, MN, FS, PCS, TD and CT have revised the manuscript.</s><s>All authors read and approved the final manuscript.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Ethics approval and consent to participate not applicable</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Consent for publication not applicable</head><p><s>Competing interests MS and TD are associate editors and MN is section editor with BMC cardiovascular disorders.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Publisher's Note</head><p><s>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Tissue advanced glycation end products are associated with diastolic function and aerobic exercise capacity in diabetic heart failure patients</title>
		<author>
			<persName><forename type="first">S</forename><surname>Willemsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Hartog</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">M</forename><surname>Hummel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Van Ruijven</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">C</forename><surname>Van Der Horst</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Van Veldhuisen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Voors</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Heart Fail</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="76" to="82" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Plasma advanced glycation endproduct, methylglyoxalderived hydroimidazolone is elevated in young, complication-free patients with type 1 diabetes</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Han</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Randell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Vasdev</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Gill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Curran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Newhook</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Grant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Hagerty</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Schneider</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Biochem</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="issue">7-8</biblScope>
			<biblScope unit="page" from="562" to="569" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Plasma methylglyoxal and glyoxal are elevated and related to early membrane alteration in young, complication-free patients with type 1 diabetes</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Han</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Randell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Vasdev</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Gill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Gadag</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Newhook</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Grant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Hagerty</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Cell Biochem</title>
		<imprint>
			<biblScope unit="volume">305</biblScope>
			<biblScope unit="issue">1-2</biblScope>
			<biblScope unit="page" from="123" to="131" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Advanced glycation end products as environmental risk factors for the development of type 1 diabetes</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">Y</forename><surname>Yap</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Kantharidis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Coughlan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Slattery</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Forbes</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Drug Targets</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="526" to="540" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Advanced glycation end products in children with type 1 diabetes and early reduced diastolic heart function</title>
		<author>
			<persName><forename type="first">L</forename><surname>Brunvand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Heier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Brunborg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">F</forename><surname>Hanssen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Fugelseth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Stensaeth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Dahl-Jorgensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">D</forename><surname>Margeirsdottir</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Cardiovasc Disord</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">133</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)developed with the special contribution of the heart failure association (HFA) of the ESC</title>
		<author>
			<persName><forename type="first">P</forename><surname>Ponikowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Voors</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Anker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Bueno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Cleland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Coats</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Falk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Gonzalez-Juanatey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">P</forename><surname>Harjola</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Jankowska</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Heart J</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="issue">27</biblScope>
			<biblScope unit="page" from="2129" to="2200" />
			<date type="published" when="2016">2016. 2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Early reduced myocardial diastolic function in children and adolescents with type 1 diabetes mellitus a population-based study</title>
		<author>
			<persName><forename type="first">L</forename><surname>Brunvand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Fugelseth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Stensaeth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Dahl-Jorgensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">D</forename><surname>Margeirsdottir</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Cardiovasc Disord</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page">103</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Diabetes mellitus-associated vascular impairment: novel circulating biomarkers and therapeutic approaches</title>
		<author>
			<persName><forename type="first">D</forename><surname>Tousoulis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Papageorgiou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Androulakis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Siasos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Latsios</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Tentolouris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Stefanadis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Coll Cardiol</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="667" to="676" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Diabetes mellitus and vascular endothelial dysfunction: current perspectives</title>
		<author>
			<persName><forename type="first">D</forename><surname>Tousoulis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Kampoli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Stefanadis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Vasc Pharmacol</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="19" to="32" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Endothelial dysfunction in diabetes: the role of reparatory mechanisms</title>
		<author>
			<persName><forename type="first">A</forename><surname>Avogaro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Albiero</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Menegazzo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>De Kreutzenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">P</forename><surname>Fadini</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="S285" to="S290" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Role of endothelial dysfunction in atherosclerosis</title>
		<author>
			<persName><forename type="first">J</forename><surname>Davignon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Ganz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">109</biblScope>
			<biblScope unit="issue">23</biblScope>
			<biblScope unit="page" from="I27" to="32" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
	<note>Suppl 1</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Transgenic activation of the kallikrein-kinin system inhibits intramyocardial inflammation, endothelial dysfunction and oxidative stress in experimental diabetic cardiomyopathy</title>
		<author>
			<persName><forename type="first">C</forename><surname>Tschöpe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Walther</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Escher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Spillmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Du</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Altmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Schimke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bader</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">F</forename><surname>Sanchez-Ferrer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">P</forename><surname>Schultheiss</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">FASEB J</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">14</biblScope>
			<biblScope unit="page" from="2057" to="2059" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Prevention of cardiac fibrosis and left ventricular dysfunction in diabetic cardiomyopathy in rats by transgenic expression of the human tissue kallikrein gene</title>
		<author>
			<persName><forename type="first">C</forename><surname>Tschöpe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Walther</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Koniger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Spillmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Westermann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Escher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Pauschinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Pesquero</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bader</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">P</forename><surname>Schultheiss</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">FASEB J</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="828" to="835" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Improvement of defective sarcoplasmic reticulum Ca2+ transport in diabetic heart of transgenic rats expressing the human kallikrein-1 gene</title>
		<author>
			<persName><forename type="first">C</forename><surname>Tschöpe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Spillmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Rehfeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Koch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Westermann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Altmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Dendorfer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Walther</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bader</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Paul</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">FASEB J</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">15</biblScope>
			<biblScope unit="page" from="1967" to="1969" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
